Chairman and Chief Executive Officer Al Davies, MD

Al Davies, MD (60) is the founder of PatientCentral Technologies, Inc. (2002), a patient-centered healthcare software business and the closely related MD Emporium, LLC (2011), a physician – directed healthcare software marketing company. Dr. Davies is in active clinical practice of Critical Care Medicine and is the founding principal of Medical Center Intensivists, PA (2004) in Houston, Texas. Dr. Davies was a cofounder of Biodyne, Inc. (1992), a successful company that created three dimensional simulations for educational, engineering, marketing and business purposes, at the very beginning of the use of these kinds of simulations. Dr. Davies founded several other companies: MediScene, Ltd (1996), a patient education and information portal, Systematic Rehab, LLC (2000), a successful provider of rehabilitation equipment for pulmonary rehabilitation centers, and Intubation Corporation (2002), a critical care medicine hardware development company.

Dr. Davies holds a B.S. in Chemistry from the University of Utah (1971) as well as an M.D. from the University of Utah School of Medicine (1975). He did an Internship and Residency in Internal Medicine at Duke University Medical Center (1975 to 1977), then a Clinical Endocrinology Fellowship at Duke University Medical Center (1977 to 1978). His Research Fellowship in Molecular Biology was in the laboratory of Robert J. Lefkowitz, M.D. at Duke University Medical Center (1978 to 1980). Dr. Davies obtained Critical Care Medicine Training, in the Division of Allergy, Critical Care, and Pulmonary Medicine, Duke University Medical Center, (1980). Dr. Davies has certified in Internal Medicine, Endocrinology and Metabolism, and Critical Care Medicine. He is licensed in Texas.

After training, Dr. Davies joined the faculty of Duke University, and became the Director of the Medical Intensive Care Unit. In 1984 he joined the faculty of Baylor College of Medicine where he worked clinically in the Emergency Room at Ben Taub Hospital, The MICUs at Ben Taub Hospital and The Methodist Hospital. He became the Program Director for the largest Critical Care Medicine Training Program along with serving as the Medical Director of the MICU at The Methodist Hospital and eventually the Acting Chief, Pulmonary and Critical Care Medicine Section, Baylor College of Medicine. He was an Associate Professor of Medicine and Assistant Professor of Physiology and Molecular Biophysics. Dr. Davies was responsible for teaching a large number of medical students, mid-level providers, residents in Internal Medicine, Anaesthesia, and Gynecology, fellows in Pulmonary and Critical Care Medicine and Cardiology and visiting scientists from both US and foreign medical schools. Dr. Davies has been an invited consultant in Pulmonary / Critical Care Medicine in Switzerland, Great Britain, India, Dubai, Guatemala, and Brazil, including medical care of critically ill patients around the globe. He has been invited to advise on medical delivery, hospital operations and design of ICUs in those countries. He has given 20 invited scientific and medical presentations nationally and internationally on topics ranging from beta adrenergic receptor molecular biology to critical care medicine and ethics, in addition to more than 12 invited Medical Grand Rounds presentations on various topics in Critical Care Medicine and Ethics. He was named among Best Doctors by Best Doctors, Inc., 2002, 2003, 2005, 2009, and 2010

Dr. Davies has received many research grants from the National Institutes of Health, American Heart Association and American Lung Association for work in adrenergic receptor biochemistry. Adrenergic receptors are proteins on the surfaces of cells to which adrenaline and similar hormones and neurotransmitters bind to stimulate biochemical cascades inside the cells to achieve physiological effect. Dr. Davies particularly explored how critical illness modifies the functions of the adrenergic receptors, and thus makes critically ill patients less capable of normal physiological responses. Dr. Davies also defined the biochemical and physiological changes that underlie mitral valve dysautonomia, a state in which responses to adrenaline are abnormally elevated, in contrast to the effects of critical illness. Dr. Davies and colleagues was the first to clone and sequence the human guanine nucleotide protein (a component of the adrenaline receptor system) in health and disease. Dr. Davies has served on editorial boards of peer reviewed scientific publications and has been reviewer for more than 18 peer reviewed scientific publications and books. Dr. Davies has contributed 29 scientific peer reviewed print publications and 41 peer reviewed scientific abstracts, in addition to many unreviewed print and internet and video contributions. Dr. Davies has been an invited reviewer for the National Institutes of Health, including the Small Business Innovation Research (SBIR) program. He has been an invited participant on several NASA committees advising on health maintenance and critical care medicine in space, for the CERV (crew emergency rescue vehicle), space shuttle, space station and the planned mission to Mars. Dr. Davies has been a consultant to the Texas State Board of Medical Examiners. In 2010 Dr. Davies was appointed to the Technical Infrastructure Work Group, Texas Health Services Authority which provides state guidance on development and operation of health information exchanges in Texas.

Relevant to the foundation of both PatientCentral Technologies, Inc. and its products, Dr. Davies has extensive experience in the management of medical school business processes, and hospital operations. At Duke University Medical Center, Dr. Davies was a member of the first Biomedical Ethics Committee, one of the first in the world. At Duke, The Methodist Hospital and Baylor College of Medicine Dr. Davies has served on the Advanced Cardiac Life Support Planning Committee, Respiratory Care Advisory Committee, Hypertension and Clinical Pharmacology Quality Assurance Committee, Task Force on ICU Patient Criteria, Pharmacy and Therapeutics Committee, Product Selection Committee - Clinical Monitoring, Medical Staff Quality Management Committee, Anaesthesia/Pain Management/Conscious Sedation Quality Management Subcommittee, MICU Renovation Group (designed new 24 bed ICU), ER / ICU Committee, Grievance Panel, Medicine Service Line Operational Committee, Nurse – Physician Communication Team, Emergency Department Redesign Committee, ICU Strategic Planning Group, CIS XA Clinical Steering Committee (selection of hospital EHR for The Methodist Hospital), Pulmonary and Critical Care Medicine Executive Committee, Pulmonary - Critical Care Medicine Fellowship Selection Committee, Resident Selection Committee, External Education Committee, Compliance Committee, Compensation and Incentives Subcommittee, and Graduate Medical Education Committee.

Dr. Davies has been Director of ACLS training, Chair, MICU Advisory Committee, Chair, Critical Care Medicine Quality Assurance, Chair, Code Blue Committee, Chair, Medical QM Subcommittee, Co-Chair, ICU Restructuring Committee, Vice Chair, Utilization Review Committee, Chair, Pulmonary – Critical Care Service Committee, Chair, Budget and Finance Committee, Liaison to Department of Medicine Executive Committee, Chair, Search Committee, Medical Director of Lung Transplantation, Chair, Search Committee, Medical Director of Sleep Program, and Associate Medical Director, Baylor Internal Medicine Consultants.

In 2004 Dr. Davies left full time employment at Baylor College of Medicine as an Associate Professor of Medicine and formed Medical Center Intensivists, PA, in order to have the crucially necessary time and capital to devote to the development of PatientCentral Technologies, LLC. He is currently a Clinical Associate Professor of Medicine at Baylor College of Medicine and continues clinical efforts as compatible with his main focus on PatientCentral Technologies, Inc.